MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

Summary: Advanced prostate cancers are treated with therapies targeting the androgen receptor (AR) signaling pathway. While many tumors initially respond to AR inhibition, nearly all develop resistance. It is critical to understand how prostate tumor cells respond to AR inhibition in order to exploi...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Preston D. Crowell, Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt, Anton Petcherski, Raag Agrawal, Matthew J. Bernard, Johnny A. Diaz, Kylie Y. Heering, Rong Rong Huang, Jin-Yih Low, Nedas Matulionis, Nora M. Navone, Huihui Ye, Amina Zoubeidi, Heather R. Christofk, Matthew B. Rettig, Robert E. Reiter, Michael C. Haffner, Paul C. Boutros, Orian S. Shirihai, Ajit S. Divakaruni, Andrew S. Goldstein
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Elsevier 2023-10-01
Sraith:Cell Reports
Ábhair:
CP: Cancer
CP: Metabolism
Rochtain ar líne:http://www.sciencedirect.com/science/article/pii/S2211124723012330

Ar líne

http://www.sciencedirect.com/science/article/pii/S2211124723012330

Míreanna comhchosúla